Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastasis From Malignant Tumor of Prostate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02125084
What this trial is testing

Enzalutamide Plus Everolimus in Men With Metastatic Castrate-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
SCRI Development Innovations, LLC 38
Testing effectiveness (Phase 2)Study completedNCT01278914
What this trial is testing

Trial of Vaccine Therapy With mRNA- Transfected Dendritic Cells in Patients With Androgen Resistant Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Oslo University Hospital
Testing effectiveness (Phase 2)Ended earlyNCT00503984
What this trial is testing

A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer Patients

Who this might be right for
Prostate CancerPain
University of Miami 22
Testing effectiveness (Phase 2)Ended earlyNCT00452387
What this trial is testing

Mitoxantrone, Prednisone Plus Sorafenib in Taxane-Refractory Metastatic Hormone Refractory Prostate Cancer (HRPC)

Who this might be right for
Metastatic Prostate Cancer
Accelerated Community Oncology Research Network 22
Early research (Phase 1)UnknownNCT05902247
What this trial is testing

Actium-225-Prostate Specific Membrane Antigen Imaging & Therapy

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Erasmus Medical Center 30
Not applicableNot Yet RecruitingNCT07560215
What this trial is testing

PROMET-BR - Molecular Profiling of Metastatic Prostate Cancer: a Brazilian Cohort

Who this might be right for
Metastatic Prostate Cancer
AstraZeneca 100
Testing effectiveness (Phase 2)Ended earlyNCT05712174
What this trial is testing

[18]F-PSMA-1007 in Patients With Known or Suspected Metastatic Prostate Cancer

Who this might be right for
OncologyProstate Cancer
AHS Cancer Control Alberta 176
Not applicableNot Yet RecruitingNCT06875297
What this trial is testing

A Single-center Prospective Interventional Study on FPG500 in Non-metastatic Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 184
Testing effectiveness (Phase 2)Study completedNCT02059213
What this trial is testing

A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
University of Michigan Rogel Cancer Center 72
Large-scale testing (Phase 3)Looking for participantsNCT06931340
What this trial is testing

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

Who this might be right for
Castration-Sensitive Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8
Alliance for Clinical Trials in Oncology 1,260
Not applicableStudy completedNCT04590976
What this trial is testing

Metastatic Prostate Cancer Men's Attitudes Towards Treatment of the Local Tumour and Metastasis Evaluative Research

Who this might be right for
Prostate Cancer MetastaticRadiotherapy Side EffectSurgery+4 more
Imperial College London 320
Not applicableLooking for participantsNCT00923221
What this trial is testing

Collection of Blood From Patients With Prostate Cancer

Who this might be right for
Cancer Of ProstateProstate CancerProstatic Neoplasms+2 more
National Cancer Institute (NCI) 1,000
Early research (Phase 1)Study completedNCT02141659
What this trial is testing

TAK-385 in Hormone Treatment-naïve Participants With Prostate Cancer

Who this might be right for
Hormone Treatment-naïve Participants With Prostate Cancer
Takeda 43
Not applicableLooking for participantsNCT06202248
What this trial is testing

Alpha Radiation Emitters Device (DaRT) for the Treatment of Non-Metastatic Locally Recurrent Prostate Cancer.

Who this might be right for
Non-metastatic Prostate CancerLocally Recurrent Prostate Cancer
Alpha Tau Medical LTD. 10
Testing effectiveness (Phase 2)Study completedNCT02499835
What this trial is testing

Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate Cancer

Who this might be right for
Hormone-Resistant Prostate CancerMetastatic Malignant Neoplasm in the BoneMetastatic Malignant Neoplasm in the Soft Tissues+4 more
University of Wisconsin, Madison 66
Large-scale testing (Phase 3)Active Not RecruitingNCT04446117
What this trial is testing

Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC

Who this might be right for
Metastatic Prostate CancerProstate Adenocarcinoma
Exelixis 575
Testing effectiveness (Phase 2)Study completedNCT01940276
What this trial is testing

Abiraterone Race in Metastatic Castrate-resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Duke University 100
Early research (Phase 1)Study completedNCT00808418
What this trial is testing

Determine the Maximum Tolerated Dose of Elesclomol Sodium Given With a Fixed Dose of Docetaxel and Prednisone in Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Synta Pharmaceuticals Corp. 34
Not applicableStudy completedNCT03672396
What this trial is testing

Home-based Exercise Intervention for Patients With Metastatic Prostate Cancer

Who this might be right for
Castration-resistant Prostate CancerAndrogen Deprivation Therapy
UNC Lineberger Comprehensive Cancer Center 22
Early research (Phase 1)Study completedNCT01303705
What this trial is testing

Anti-OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate CancerCancer of the ProstateProstate Cancer
Providence Health & Services 13
Next Page